|
|
| (9 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| <StructureSection load='1ktz' size='340' side='right' caption='Human hTGFBR-II extracellular domain (green) complex with TGF-β3 (grey) (PDB code [[1ktz]])' scene=''> | | <StructureSection load='1ktz' size='340' side='right' caption='Human hTGFR-II extracellular domain (green) complex with TGF-β3 (grey) (PDB code [[1ktz]])' scene=''> |
| __TOC__ | | __TOC__ |
| == Function == | | == Function == |
| '''TGF-β receptors''' (Transforming Growth Factor) (TGFBR) are serine/threonine kinase receptors. They are involved in paracrine signaling and are found in many types of tissue. TGF-β ligands include bone morphogenetic proteins, growth and initiation factors, anti-Mullerian hormone, activin, nodal TGF-β<ref>PMID:9525694</ref>. There are 3 types of TGFBR: <br /> | | '''TGF-β receptors''' (Transforming Growth Factor) (TGFR) are [[serine/threonine kinase]] receptors. They are involved in paracrine signaling and are found in many types of tissue. TGF-β ligands include bone morphogenetic proteins, growth and initiation factors, anti-Mullerian hormone, activin, nodal TGF-β<ref>PMID:9525694</ref>. There are 3 types of TGFR: <br /> |
| *'''TGFBR I''' forms heteromeric complex with TGFBR II when it is bound to TGF-β. The complex transduces the TGF-β signal from the cell surface to the cytoplasm by phosphorylating proteins which regulate the transcription of genes related to cell proliferation. TGFBR I has high affinity for TGF-β1 and low affinity for TGF-β2. <br /> | | *'''TGFR I''' forms heteromeric complex with TGFR II when it is bound to TGF-β. The complex transduces the TGF-β signal from the cell surface to the cytoplasm by phosphorylating proteins which regulate the transcription of genes related to cell proliferation. TGFR I has high affinity for TGF-β1 and low affinity for TGF-β2. <br /> |
| *'''TGFBR II''' is a tumor suppressor transmembrane protein. TGFBR II has high affinity for TGF-β1 and low affinity for TGF-β2. <br /> | | *'''TGFR II''' is a tumor suppressor transmembrane protein. TGFR II has high affinity for TGF-β1 and low affinity for TGF-β2. <br /> |
| *'''TGFBR III''' is a cell-surface chondroitin sulfate / heparin sulfate proteoglycan. It acts as a reservoir of ligand for TGFBRs. TGFBR III has high affinity for TGF-β1, TGF-β2 and TGF-β1.2. | | *'''TGFR III''' is a cell-surface chondroitin sulfate / heparin sulfate proteoglycan. It acts as a reservoir of ligand for TGFRs. TGFR III has high affinity for TGF-β1, TGF-β2 and TGF-β1.2. |
| | |
| | See also [[Receptor]], [[TGF beta signaling pathway]], and [[Growth factors]]. |
|
| |
|
| == Disease == | | == Disease == |
|
| |
|
| Over-expression of TGF causes kidney disease, diabetes and renal disease. Mutations in TGFBR II cause various types of tumors<ref>PMID:23884466</ref>. | | Over-expression of TGF causes kidney disease, diabetes and renal disease. Mutations in TGFR II cause various types of tumors<ref>PMID:23884466</ref>. |
|
| |
|
| == Structural highlights == | | == Structural highlights == |
| TGFBR structure contains a 100-140 residues ligand-binding N-terminal extracellular domain; a transmembrane domain; a 350-400 amino acid cytoplasmic kinase domain; and a C-terminal zona pellucida (ZP) domain of ca 260 residues which has a role in protein polymerization.
| | TGFR structure contains a 100-140 residues ligand-binding N-terminal extracellular domain; a transmembrane domain; a 350-400 amino acid cytoplasmic kinase domain; and a C-terminal zona pellucida (ZP) domain of ca 260 residues which has a role in protein polymerization. |
| | |
| | == 3D Structures of TGF-beta receptor== |
| | [[TGF-beta receptor 3D structures]] |
|
| |
|
| </StructureSection> | | </StructureSection> |
|
| |
|
| == 3D Structures of TGF-β receptor==
| |
|
| |
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| |
| {{#tree:id=OrganizedByTopic|openlevels=0|
| |
|
| |
| * TGF-β receptor I; kinase domain 200-503
| |
|
| |
| **[[1ias]], [[5e8s]] – hTGFBR-I kinase domain – human <br />
| |
| **[[5e8t]], [[5e8u]] – hTGFBR-I kinase domain (mutant) <br />
| |
| **[[5e8w]], [[5e8x]] – hTGFBR-I kinase domain (mutant) + staurosporine<br />
| |
| **[[5e8z]] – hTGFBR-I kinase domain (mutant) + inhibitor<br />
| |
| **[[2l5s]] – hTGFBR-I extracellular domain - NMR<br />
| |
| **[[1b6c]] – hTGFBR-I kinase domain + FKBP12 <br />
| |
| **[[1py5]], [[3faa]], [[3gxl]], [[3hmm]], [[2wot]], [[2wou]], [[3kcf]], [[2x7o]], [[3tzm]], [[4x0m]], [[4x2j]], [[4x2k]], [[4x2n]] – hTGFBR-I kinase domain + inhibitor <br />
| |
| **[[1vjy]] – hTGFBR-I residues 1-303 + inhibitor <br />
| |
| **[[5usq]] – hTGFBR-I residues 123-421 + inhibitor <br />
| |
| **[[1rw8]] – hTGFBR-I truncated kinase domain + inhibitor <br />
| |
|
| |
| * TGF-β receptor II
| |
|
| |
| **[[1m9z]] – hTGFBR-II extracellular domain <br />
| |
| **[[1plo]], [[4p7u]] – hTGFBR-II extracellular domain (mutant) - NMR<br />
| |
| **[[5e8v]] – hTGFBR-II kinase domain (mutant) <br />
| |
| **[[5e8y]] – hTGFBR-II kinase domain (mutant) + staurosporine<br />
| |
| **[[5e92]] – hTGFBR-II kinase domain (mutant) + AMPPNP<br />
| |
| **[[1ks6]] – cTGFBR-II extracellular domain - chicken<br />
| |
| **[[1ktz]] – hTGFBR-II extracellular domain + TGF-β3 <br />
| |
| **[[5ty4]] – hTGFBR-II extracellular domain + mmTGF-β2 <br />
| |
| **[[5tx4]] – mTGFBR-II extracellular domain (mutant) + hTGF-β2 - mouse<br />
| |
|
| |
| * TGF-β receptor III
| |
|
| |
| **[[3qw9]] – TGFBR-III ZP-C domain - rat<br />
| |
| **[[4ajv]] – mTGFBR-III ZP-C domain <br />
| |
|
| |
| * TGF-β receptor I+II
| |
|
| |
| **[[2pjy]] – hTGFBR-I extracellular domain (mutant) + hTGFBR-II extracellular domain (mutant) + TGF-β3 <br />
| |
| **[[3kfd]] – hTGFBR-I extracellular domain + hTGFBR-II extracellular domain + TGF-β1 <br />
| |
| }}
| |
| == References == | | == References == |
| <references/> | | <references/> |
| [[Category:Topic Page]] | | [[Category:Topic Page]] |